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A case of Naegleria fowleri related primary
amoebic meningoencephalitis in China
diagnosed by next-generation sequencing
Qiang Wang1,2†, Jianming Li1†, Jingkai Ji3,6†, Liuqing Yang1, Li Chen1, Rongrong Zhou1, Yang Yang1,2,
Haixia Zheng1, Jing Yuan1, Liqiang Li3,6, Yuhai Bi1,2, George F. Gao1,2,4,5, Jinmin Ma3,6,7* and Yingxia Liu1,5*
Abstract
Background: Primary amoebic meningoencephalitis (PAM), caused by Naegleria fowleri, is a rare protozoan
infectious disease in China. A fatality rate of over 95% had been reported due to extremely rapid disease
progression in the USA and other countries. Rapid and precise identification of the causative agent is very
important to clinicians for guiding their choices for administering countermeasures in the clinic. In this report, we
applied the next-generation sequencing (NGS) method to rapidly show that N. fowleri was the causative agent of a
fatal case involving a 42-year-old man with severe PAM disease, the first reported in mainland China.
Case presentation: A 42-year old male in a deep coma was admitted to Shenzhen Third People’s Hospital, a
special medical care unit with expertise in infectious diseases. Increased intracranial pressure was detected. The
cerebrospinal fluid (CSF) sample was found to be red and cloudy with increased leukocyte and protein levels. While
bacterial cultures with CSF were negative, N. fowleri was determined to be the causative agent with NGS.
Amphotericin B (AmB), a drug with anti-amoeba activity, was used immediately, but the treatment came too late
and the patient died 2 days after the NGS confirmation.
Conclusion: In this paper, we reported a case of PAM disease for the first time in mainland China. NGS was used
for rapid diagnosis and provided guidance for prescribing medications. However, the patient died due to a late
admission amid advanced PAM disease. Early detection of N. fowleri is necessary in order to select effective drug
treatments and control the disease progression. Despite the negative survival outcome, NGS was shown to be a
promising method of rapid and precise identification of N. fowleri.
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Background
Primary amoebic meningoencephalitis (PAM) is an acute
and rapidly fatal disease of the central nervous system,
caused by infection with Naegleria fowleri, a thermo-
philic free-living amoeba found in warm freshwater such
as lakes, ponds, rivers and hot springs [1]. Contaminated
tap water could also be a source of infection [2]. N. fow-
leri usually infects people through the nose cavity when
in contact with contaminated water. N. fowleri is com-
monly known as a “brain-eating amoeba” because of its
induction of severe encephalitis in the brain upon infec-
tion, with a fatality rate of over 95% [3]. There are over
40 species of Naegleria, but only N. fowleri infections re-
sults in PAM [1]. PAM has a rapid, acute disease pro-
gression, with an incubation period varying from 2 to
15 days, and death typically occurring 3–7 days after the
onset of symptoms [1]. N. fowleri has been reported
worldwide including America, Australia, Thailand, Hong
Kong and Taiwan [4], and about 300 cases in total have
been reported in 50 years since the first case was re-
ported in 1965 [3]. Prompt diagnosis is important in
order to start treatment as soon as possible. However,
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prompt diagnosis is not easy for those who had no ex-
perience in treatment of N. fowleri infection and PAM is
often misdiagnosed because no distinctive differences in
diagnosis exist to distinguish PAM from bacterial men-
ingoencephalitis [5]. In this study, we report using the
next generation sequencing (NGS) method for prompt
diagnosis of a N. fowleri-related infection, the first case
in mainland China.
Case presentation
On 20th August 2016, a 42-year-old man with a fever
(38.4 °C) was admitted to a local hospital in Hangzhou
City, China. He lived in Shenzhen City, but was visiting
Hangzhou at the time. His disease began with a head-
ache 1 day earlier. Upon admission, blood tests showed
a leukocytosis of 10.48 × 109/L (80% neutrophils). On
the night of admission, a lumbar puncture showed high
levels of white blood cells (WBCs, 1170 cells/ μL, 83%
neutrophils), a protein concentration of 3.0 g/L and a
glucose concentration of 1.0 mmol/L in the cerebro-
spinal fluid (CSF) sample. He was treated with 2.0 g of
the antimicrobial ceftriaxone and his situation was not
improved.
One day later, the patient’s speech became incoherent
and he experienced dyspnea. He was transferred to the
intensive care unit and endotracheal intubation was ap-
plied. He was administered combined therapy compris-
ing of antibiotics (meropenem and linezolid) and an
anti-inflammatory drug (dexamethasone). During the
night, the patient was found in a coma with dilated bilat-
eral pupils. Computed tomography scans of his brain il-
lustrated hydrocephalus, cerebral edema and foggy brain
ventricles. Ventricle puncture for external CSF drainage
was performed to reduce intracranial pressure. Four days
after admission, microbial culture results of the CSF
samples were negative for bacteria and fungi.
On 31th August, the patient was taken back to Shen-
zhen at the request of his family, and transferred to
Shenzhen Third People’s Hospital, the key institute for
handling infectious disease cases. At the time of admis-
sion, he was already in a deep coma and unresponsive
to simple cues. A blood test showed a leukocytosis of
14.72 × 109 /L (93.3% neutrophils). The CSF appeared
light red in color and was mixed with cloudy debris.
The WBC count in the CSF had increased substantially
to 52,860 cells/ μL (79% lymphocytes), whereas the pro-
tein level had increased to 49.96 g/L and the glucose
concentration was 0.11 mmol/L. Computed tomog-
raphy scans showed severe brain swelling. The shape of
the cerebral ventricles had become twisted and almost
disappeared (Fig. 1).
His CSF sample was immediately sent for pathogen
detection by NGS at BGI-Shenzhen. Briefly, the CSF
sample was centrifuged at 10,000×g for 10 min and the
precipitate was used for nucleic acid extraction using the
QIAamp DNA Mini Kit (Qiagen), following manufac-
turer instructions. NGS was performed on the newly de-
veloped BGISEQ-500 platform [6]. The sequencing
detection identified 65,658 (out of 246,938,950) sequence
reads (0.0266%) uniquely corresponding to the N. fowleri
genome (Fig. 2b) [7], and these reads covered a high per-
centage of the genome (Fig. 2a). When the reads from
the human host were excluded, N. fowleri reads were
comprised the most of any microbial species, accounting
for 0.3689% of total microbial reads and unknown or un-
classified reads (Fig. 2c), and more than the total reads
of bacterium or fungi (Additional file 1). A 1.6-kb con-
sensus sequence of the 18S ribosomal RNA of N. fowleri
was assembled (GenBank accession no.KY062165) and
found to be 99.99% identical to a reference N. fowleri se-
quence (GenBank accession no. U80059). N. fowleri in-
fection was confirmed by PCR (Fig. 3) using the specific
primers NFITS-FW (TGAAAACCTTTTTTCCATTTA
CA) and NFITS-RV (AATAAAAGATTGACCATTTGA
AA) covering the 5.8S ribosomal DNA and internal tran-
scribed spacer 2 [4]. Therefore, all these results indicate
that the patient was infected with N. fowleri. In addition,
patient history collected from family members showed
that the man was splashed by lake water when he
attended the Water-Splashing Festival in Shenzhen ap-
proximately 1 weeks before symptoms onset, which may
be the source of infection. Anti-amoebic drugs including
amphotericin B (AmB) at 50 mg/day and fluconazole
0.4 g/day were immediately administered. Unfortunately,
symptoms did not improve and the patient’s family re-
quested to cease medical treatment 2 days later. Life
Fig. 1 Computed tomography scan of the patient brain with
primary amoebic meningoencephalitis
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support was withdrawn and the patient was pronounced
dead on 3rd September.
Discussion
We report here a fatal case of PAM caused by N. fowleri
infection, in which infection likely occurred after the pa-
tient had direct contact with lake water 2 weeks before
the onset of symptoms. This is the first case of N. fowler-
i-related PAM reported in mainland China. Only two
cases were report in Hong Kong and Taiwan, respect-
ively. Although three suspected fatal PAM cases in
mainland China had been documented in Chinese jour-
nals during 1978, 1990 and 2001, respectively (Table 1),
the causative pathogen was never conclusively identified.
Increased levels of leukocytes and protein, and a de-
crease in glucose levels, were consistently observed in all
six cases during the disease course.
PAM is acute and aggressive, with death typically oc-
curring 3–7 days after onset of symptoms. Early diagno-
sis and rapid treatment with the appropriate drugs are
key factors for effective therapy. In the current case, the
man had a suspected incubation period of 5 days and
died 15 days after disease onset. Although N. fowleri was
identified in only 2 days after his admission to Shenzhen
Third People’s Hospital, the patient was already in a
Fig. 2 Diagnosis of N. fowleri infection using the NGS method. a. mapping of N. fowleri reads on the genome. b. Reads distribution of total DNA
in the CSF sample. c. Reads distribution of microbes and unknown reads in the absence of human host reads
Fig. 3 PCR detection of N. fowleri from CSF specimen. Lane M: DNA
ladder. Lane 1: Negative control. Lane 2: 309-bp PCR product of the
5.8S ribosomal DNA and internal transcribed spacer 2 region of
N. fowleri
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comatose state, indicating advanced, severe illness.
Anti-amoeba medical treatment was initiated 11 days
after the onset of disease symptoms; therefore, treat-
ment with the appropriate drugs likely occurred too
late to abate the acute phase of PAM.
NGS played a critical role in the accurate diagnosis of
N. fowleri in the present case. By contrast, the amoeba
was not identified in culture. Therefore, NGS constitutes
a rapid and accurate method for the identification of
pathogens and is particularly helpful in the diagnosis of
diseases with unknown causes.
Although no clinically approved specific drugs were
available, AmB and miltefosine were reported in success-
ful treatment of N. fowleri related PAM. AmB, which is a
common drug in clinic and is primarily used as an anti-
fungal medication, has an amoebicidal effect and has been
used to treat PAM since 1970. However, the recovery rate
with AmB is only 5% (15 recoveries/300 cases worldwide),
and this drug can be toxic to humans [3]. Miltefosine, a
drug developed against breast cancer and Leishmania in-
fections, possesses activity against free-living amoeba spe-
cies in vitro [8, 9], and is now recommended for the
treatment of PAM by the Centers for Disease Control and
Prevention in the USA [10], while is not currently avail-
able in China. In the United States, 143 PAM cases have
been reported, with only four survivors between 1962 and
2016 [11, 12] . Notably, two of the four survivors were re-
lated to miltefosine treatment. In 2013 an American girl
was diagnosed as PAM about 36 h after symptom onset
and was given the recommended miltefosine therapy. She
recovered completely without any neurologic impair-
ment [13]. In contrast, an 8 years-old boy was identi-
fied with PAM more than 3 days after disease onset.
He survived with brain damage although he was also
given the recommended miltefosine therapy [14]. Al-
though miltefosine-containing treatment regimen
could offer a survival advantage for patients with fatal
infections by free-living amoeba, recovery is not as-
sured, since at least three fatal PAM cases were also
reported with receiving miltefosine treatment [14, 15].
In addition, miltefosine should be administered in
combination with AmB and other drugs, such as ri-
fampin and fluconazole, as soon as possible after
diagnosing PAM. In addition to drug treatment, phys-
ical procedures like CSF drainage, hyperosmolar ther-
apy, moderate hyperventilation and hypothermia have
been employed in the treatment of PAM [3, 16].
Although PAM is a rare disease in China, the rapid
disease process and very high fatality rate make it a very
dangerous disease. Unfortunately, we have no data about
the distribution range of the pathogenic N. fowleri in
mainland China. More related research should be car-
ried out to analyze the epidemiological risk of N. fowleri
in China. On the other hand, development of more spe-
cific drugs against N. fowleri should be put on schedule.
Most previous cases of PAM have been found to have
been infected with N. fowleri during recreational activ-
ities involving freshwater [17]. In the current case, the
patient participated in a Water-Splashing Festival several
days before the onset of disease; it is therefore likely that
contaminated water was the source of infection. This
case is a warning that care should be taken when partici-
pating in recreational activities involving freshwater due
to the possibility of contamination.
Conclusion
In the current report, a N. fowleri-related PAM was rap-
idly diagnosed using NGS. Although the patient died,
Table 1 Primary amoebic meningoencephalitis cases reported in China and neighboring places
Age Gender Location Year First CSF after admission Amoebicidal
Treatment
Days from
symptom
onset to death
Diagnosis
WBC
(cells/μL)
N
%
L
%
Glucose
(mmol/L)
Protein (g/
L)
17 male Henanb 1978 50 5 95 2.95 1.52 NA 10 days Amoebic trophozoites were
observed in the brain tissue
after death.
21 male Beijingb 1990 300 70 30 3.4 0. 5 NA 7 days Amoebic trophozoites were
found in the CSF after death.
23 male Hainanb 2001 22,000 85 NA 2.2 2 none 6 days Amoebic trophozoites were
detected in the CSF before death.
38 male Hong
Kong
1993 NA NA NA NA NA AmB, rifampicin survival Amoeba were observed in an
abscess biopsy.
75 male Taiwan 2011 560 90.5 5 2.2 9.5 AmB 25 daysa Amoebic trophozoites were
detected in the CSF.
42 male Shenzhen 2016 1170 83 12 1 3 AmB,
fluconazole
15 days Next-generation sequencing
CSF Cerebrospinal fluid, WBC White blood cells, N Neutrophils, L Lymphocytes, NA Not available
aDays after the start of AmB treatment
bSuspected cases documented in Chinese journals without an English citation version
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the NGS method was shown to be of use to rapidly iden-
tify the causative pathogen in the clinic, especially for
PAM. The NGS method should be more widely applied
in clinical practices, helping physicians on diagnosis and
advising on choice of medical countermeasures in the
clinic to save lives.
Additional file
Additional file 1: Microbe reads counts. Other microbe reads including
that of bacterium, fungi and virus were listed in the excel table. (XLSX 19 kb)
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